SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Cell Genesys (CEGE)
An SI Board Since April 1996
Posts SubjectMarks Bans Symbol
1298 85 0 CEGE
Emcee:  Bharat Kalra Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1198>>ORLANDO, Fla., May 21 /PRNewswire-FirstCall/ -- Cell Genesys, Inc. (Nasdtuck-5/21/2002
1197Here's the corrected version of the May 13 story: Reuters Company News CORRCzechsinthemail-5/21/2002
1196>>ORLANDO, Fla., May 19 /PRNewswire-FirstCall/ -- Cell Genesys, Inc. (Nasdtuck-5/19/2002
1195Cash, prospects alleviate pain for tiny US biotech By Bill Berkrot NEW YORK, david james-5/13/2002
1194Glad you posted that. The scene evolved while my attention was elsewhere. MessMark Adams-5/4/2002
1193The company is selling at a modest premium to cash (the premium being roughly $2Londo-5/4/2002
1192Stocks selling below cash on hand? Message 17419965 I've purchased a few oMark Adams-5/4/2002
1191Cell Genesys Reports First Quarter Results Ends Quarter with $230.3 Million in CSemiBull-4/22/2002
1190Ceregene Expands Into New Facility SAN DIEGO, April 18 /PRNewswire/ -- CeregeneSemiBull-4/18/2002
1189Cell Genesys Reports Positive Preclinical Studies of Oncolytic Virus Therapy ForSemiBull-4/10/2002
1188Cell Genesys To Discontinue License Agreement With GPC Biotech For P27/P16 Gene nigel bates-3/21/2002
1187Cell Genesys To Discontinue Gene Pact With GPC Biotech DOW JONES NEWSWIRES FOSmopgcw-3/21/2002
1186Transkaryotic In Settlement On Gene Therapy Patent CAMBRIDGE, Mass. -(Dow JonesSemiBull-3/19/2002
1185Ceregene Announces Additions to Management Team Dominick Vacante, Ph.D., and BrSemiBull-3/7/2002
1184Ceregene Announces Additions to Management Team Dominick Vacante, Ph.D., and BrSemiBull-3/7/2002
1183Cell Genesys Invites You to Join Its Company Presentation at the BIO CEO And InvSemiBull-2/20/2002
1182Cell Genesys Secures Memphis Facility for Manufacturing of Patient-Specific LungSemiBull-2/12/2002
1181>>FOSTER CITY, Calif., Feb. 5 /PRNewswire-FirstCall/ -- Cell Genesys, Inc.tuck-2/5/2002
1180I speculate that they will sell ABGX when they believe the price is right or wheMadharry-2/4/2002
1179Any speculation on what this company's Abgenix exit strategy is going to be?Londo-2/2/2002
1178Cell Genesys Reports Fourth Quarter and 2001 Results Ends Year With $259 MillioSemiBull-1/28/2002
1177Ceregene-Licensed Alzheimer's Gene Therapy Featured In CNN Coverage SAN DIESemiBull-1/28/2002
1176Cell Genesys, Inc. Invites You to Join Its Fourth Quarter/Year-End Conference CaSemiBull-1/23/2002
1175Cell Genesys Appoints Michael Ramsay Vice President of Manufacturing Operations SemiBull-1/8/2002
1174Abgenix aims for clinical trials of 2 more drugs Message 16880126SemiBull-1/8/2002
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News